Clinical Trial Update: Study to Compare Pediacel® to Infanrix®-IPV+Hib When Both Are Co-Administered With Prevenar® in Infants and Toddlers [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing Pediacel to Infanrix-IPV+Hib when co-administered with Prevenar in infants and toddlers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diphtheria
• Haemophilus Influenzae Type
• Pertussis
• Poliomyelitis
• Tetanus

Drugs mentioned

• Infanrix IPV/Hib (Diphtheria, Tetanus, Acellular Pertussis, Inactivated Poliovirus, Haemophilus influenzae type b vaccine (DTaP-IPV-Hib))
• Pediacel (Diphtheria, Tetanus, Acellular Pertussis, Inactivated Poliovirus, Haemophilus influenzae type b, Hepatitis B vaccine (DTaP-IPV-Hib-HepB))
• Prevenar (pneumococcal conjugate vaccine)

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Diphtheria, Tetanus | Phase 3 | Status: COMPLETED